Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 DKK)

NET PROFIT (x1000 DKK)

EMPLOYEES

Share

Immunopharma AS

Closing information (x1000 DKK)

Closing information 2022/12 (consolidated) 2021/12 (consolidated) 2020/12 (consolidated)
Turnover 340,533 Less Arrow 291,360 Less Arrow 223,978
Financial expenses 6,869 More Arrow 7,434 More Arrow 8,332
Earnings before taxes -35,125 More Arrow -17,348 More Arrow -13,843
Total assets 269,269 Less Arrow 261,886 More Arrow 276,750
Current assets 162,420 Less Arrow 98,399 Less Arrow 73,580
Current liabilities 75,511 Less Arrow 55,520 Less Arrow 50,913
Equity capital 144,427 More Arrow 181,884 Less Arrow 97,649
- share capital 9,795 More Arrow 9,975 Less Arrow 7,368
Employees (average) 8 Less Arrow 1

Financial ratios

Fiscal year 2022/12 (consolidated) 2021/12 (consolidated) 2020/12 (consolidated)
Solvency 53.6% More Arrow 69.5% Less Arrow 35.3%
Turnover per employee 36,420 More Arrow 223,978
Profit as a percentage of turnover -10.3% More Arrow -6.0% Less Arrow -6.2%
Return on assets (ROA) -10.5% More Arrow -3.8% More Arrow -2.0%
Current ratio 215.1% Less Arrow 177.2% Less Arrow 144.5%
Return on equity (ROE) -24.3% More Arrow -9.5% Less Arrow -14.2%
Change turnover 64,477 Less Arrow 55,313 More Arrow 222,325
Change turnover % 23% Equal arrow 23% More Arrow 13447%
Chg. No. of employees 7 Less Arrow 0
Chg. No. of employees % 700% Less Arrow 0%

Total value of public sale

Fiscal year 2022/12 (consolidated) 2021/12 (consolidated) 2020/12 (consolidated)
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.